EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models

Pritha Mukherjee iD, Xin Zhou, Susana Galli iD, Bruce Davidson, Lihua Zhang, Jaeil Ahn iD, Reem Aljuhani, Julius Benicky, Laurie Ailles, Vitor H Pomin iD, Mark Olsen iD, Radoslav Goldman iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094998 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Pritha Mukherjee und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. Hauptthemen laut MEDLINE: Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Neoplasm Invasiveness, Cell Movement. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, The National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aspartate β-hydroxylase (ASPH) is a protein associated with malignancy in a wide range of tumors. We hypothesize that inhibition of ASPH activity could have anti-tumor properties in patients with head and neck cancer. In this study, we screened tumor tissues of 155 head and neck squamous cell carcinoma (HNSCC) patients for the expression of ASPH using immunohistochemistry. We used an ASPH inhibitor, MO-I-1151, known to inhibit the catalytic activity of ASPH in the endoplasmic reticulum, to show its inhibitory effect on the migration of SCC35 head and neck cancer cells in cell monolayers and in matrix-embedded spheroid co-cultures with primary cancer-associated fibroblast (CAF) CAF 61137 of head and neck origin. We also studied a combined effect of MO-I-1151 and HfFucCS, an inhibitor of invasion-blocking heparan 6-O-endosulfatase activity. We found ASPH was upregulated in HNSCC tumors compared to the adjacent normal tissues. ASPH was uniformly high in expression, irrespective of tumor stage. High expression of ASPH in tumors led us to consider it as a therapeutic target in cell line models. ASPH inhibitor MO-I-1151 had significant effects on reducing migration and invasion of head and neck cancer cells, both in monolayers and matrix-embedded spheroids. The combination of the two enzyme inhibitors showed an additive effect on restricting invasion in the HNSCC cell monolayers and in the CAF-containing co-culture spheroids. We identify ASPH as an abundant protein in HNSCC tumors. Targeting ASPH with inhibitor MO-I-1151 effectively reduces CAF-mediated cellular invasion in cancer cell models. We propose that the additive effect of MO-I-1151 with HfFucCS, an inhibitor of heparan 6-O-endosulfatases, on HNSCC cells could improve interventions and needs to be further explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsNeoplasm InvasivenessCell MovementHumansCell Line, TumorUp-RegulationGene Expression Regulation, NeoplasticFemaleMiddle AgedMixed Function OxygenasesMaleCoculture TechniquesAgedCalcium-Binding ProteinsMembrane ProteinsMuscle Proteins

Stichwörter der Autor:innen

HNSCCHfFucCSMO-I-1151SCC35 co-culture spheroidaspartate β-hydroxylase (ASPH)heparan 6-O-endosulfatase 2 (SULF2)primary head and neck CAF

Substanzen

ASPH protein, humanaspartic acid 2-oxoglutarate-dependent dioxygenaseMixed Function OxygenasesCalcium-Binding ProteinsMembrane ProteinsMuscle Proteins

Autor:innen und Institutionen

  • Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA.
  • Clinical and Translational Glycoscience Research Center, Georgetown University, Washington, DC 20057, USA.
  • Biotechnology Program, Northern Virginia Community College, Manassas, VA 20109, USA.
  • Department of Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC 20057, USA.
  • Department of Otolaryngology-Head and Neck Surgery, MedStar Georgetown University Hospital, Washington, DC 20057, USA.
  • Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC 20057, USA.

ORCID-Profile: Pritha Mukherjee, Susana Galli, Jaeil Ahn, Vitor H Pomin, Mark Olsen, Radoslav Goldman

Förderung

  • NCI NIH HHS
  • NIH HHS
  • The National Institutes of Health
  • CCSG

Zitieren

APA

Mukherjee, P., Zhou, X., Galli, S., Davidson, B., Zhang, L., Ahn, J., Aljuhani, R., Benicky, J., Ailles, L., Pomin, V. H., Olsen, M., & Goldman, R. (2024). Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094998

Vancouver

Mukherjee P, Zhou X, Galli S, Davidson B, Zhang L, Ahn J, et al. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094998

BibTeX
@article{Mukherjee2024,
  author = {Mukherjee, Pritha and Zhou, Xin and Galli, Susana and Davidson, Bruce and Zhang, Lihua and Ahn, Jaeil and Aljuhani, Reem and Benicky, Julius and Ailles, Laurie and Pomin, Vitor H and Olsen, Mark and Goldman, Radoslav},
  title = {Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094998}
}
Kostenlos starten →